Cargando…
Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant
As an important zoonotic protozoan, Toxoplasma gondii (T. gondii) has spread around the world, leading to infections in one-third of the population. There is still no effective vaccine or medicine against T. gondii, and recombinant antigens entrapped within nanospheres have benefits over traditional...
Autores principales: | Yu, Zhengqing, Ding, Wenxi, Aleem, Muhammad Tahir, Su, Junzhi, Liu, Junlong, Luo, Jianxun, Yan, Ruofeng, Xu, Lixin, Song, Xiaokai, Li, Xiangrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161231/ https://www.ncbi.nlm.nih.gov/pubmed/34069589 http://dx.doi.org/10.3390/pharmaceutics13050752 |
Ejemplares similares
-
With Chitosan and PLGA as the Delivery Vehicle, Toxoplasma gondii Oxidoreductase-Based DNA Vaccines Decrease Parasite Burdens in Mice
por: Yu, Zhengqing, et al.
Publicado: (2021) -
Nano DNA Vaccine Encoding Toxoplasma gondii Histone Deacetylase SIR2 Enhanced Protective Immunity in Mice
por: Yu, Zhengqing, et al.
Publicado: (2021) -
Recombinant Toxoplasma gondii Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo
por: Yu, Zhengqing, et al.
Publicado: (2021) -
Modulation Effects of Toxoplasma gondii Histone H2A1 on Murine Macrophages and Encapsulation with Polymer as a Vaccine Candidate
por: Yu, Zhengqing, et al.
Publicado: (2020) -
Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis
por: Yu, ZhengQing, et al.
Publicado: (2022)